hat
J147 se yon konpoze nouvo enteresan ki se trè ki pisan, ki an sekirite nan syans bèt ak oral aktif. J147 se yon terapetik potansyèl AD akòz kapasite li yo bay benefis imedya imedya, epi li tou gen potansyèl la sispann e petèt ranvèse pwogresyon maladi nan bèt sentòm yo. Kontrèman ak dwòg yo kounye a apwouve pou maladi alzayme a, J147 se pa ni yon inhibitor acetylcholinesterase ni yon inibitè fosfodiesteraz, men li amelyore kognisyon ak yon tretman kout tèm. Se konsa, ki sa ki j147 te fè soti nan?
eng
J147 is an exciting new compound that is extremely potent, safe in animal studies and orally active. J147 is a potential AD therapeutic due to its ability to provide immediate cognition benefits, and it also has the potential to halt and perhaps reverse disease progression in symptomatic animals. Unlike the current drugs approved for Alzheimer’s Disease, J147 is neither an acetylcholinesterase inhibitor nor a phosphodiesterase inhibitor, yet it enhances cognition with a short-term treatment. So, what is j147 made from?